Paper published in the International Journal of Molecular Sciences, June 24, 2020 (doi.org/10.3390/ijms21124493)
In an interview with Drug Development and Delivery, Lewis H. Bender, MA, MBA, says cancer is a local and systemic disease, and new forms of local treatment, such as intratumoral dosing coupled with systemic immunotherapy, are being explored.
Presentation: Intratumoral INT230-6 injection into solid tumors kills tumors and induces immune cell infiltration leading to abscopal responses and prolonged disease control in multiple refractory cancer types (NCT 03058289)
Presentation made at SITC 2019 by Dr. Jacob Thomas, Assistant Professor of Medicine, University of Southern California
Article published online July 16, 2019 in the journal OncoImmunology
Poster presented at SITC 2018
Poster presented at ESMO 2018
Poster presented at AACR 2017